<?xml version="1.0" encoding="UTF-8"?> <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"> <channel rdf:about="http://dsi.com/dsi-feed/-/journal/rss/12065/44103"> <title>Press Release Feed</title> <link>http://dsi.com/dsi-feed/-/journal/rss/12065/44103</link> <description>Press Release Feed</description> <items> <rdf:Seq> <rdf:li resource="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1182330" /> <rdf:li resource="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1160121" /> <rdf:li resource="http://dsi.com/m-news-releases" /> <rdf:li resource="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1097380" /> <rdf:li resource="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032663" /> <rdf:li resource="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032401" /> </rdf:Seq> </items> </channel> <item rdf:about="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1182330"> <title>New Guidelines From the American Association of Clinical Endocrinologists AACE Identify Welchol</title> <link>http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1182330</link> <description /> <dc:creator>Rose Ann Cotreau</dc:creator> <dc:date>2013-06-06T12:17:00Z</dc:date> </item> <item rdf:about="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1160121"> <title>Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement</title> <link>http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1160121</link> <description /> <dc:creator>Deborah Lawyer</dc:creator> <dc:date>2013-04-24T19:09:00Z</dc:date> </item> <item rdf:about="http://dsi.com/m-news-releases"> <title>First Hepatocellular Carcinoma Patient Ph3 Tivantinib</title> <link>http://dsi.com/m-news-releases</link> <description /> <dc:creator>Deborah Lawyer</dc:creator> <dc:date>2013-01-31T14:36:00Z</dc:date> </item> <item rdf:about="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1097380"> <title>Top-Line Results in Phase 2 Trial in Tivantinib with Colorectal Cancer</title> <link>http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1097380</link> <description /> <dc:creator>Deborah Lawyer</dc:creator> <dc:date>2013-01-11T14:41:00Z</dc:date> </item> <item rdf:about="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032663"> <title>Daiichi Sankyo Completes Enrollment in Hokusai – VTE, investigating once-daily Edoxaban in the Large</title> <link>http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032663</link> <description /> <dc:creator>Scott Meller</dc:creator> <dc:date>2012-10-25T03:00:00Z</dc:date> </item> <item rdf:about="http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032401"> <title>PREMIER TCT DATA / ACS-PT Patients treated with Effient and Plavix</title> <link>http://dsi.com/dsi-feed/-/journal_content/56_INSTANCE_jb9J/12065/1032401</link> <description /> <dc:creator>Deborah Lawyer</dc:creator> <dc:date>2012-10-22T15:20:00Z</dc:date> </item> </rdf:RDF> 